で公開中です！詳しく見る

Materialise

MTLS

時価総額 $4.61億

8.00 USD

-0.12

1.48%

終値時点更新済み 10月16日 16:00 EDT

1日

-1.48%

5日間

-2.44%

1か月

3.9%

3か月

19.58%

6か月

50.66%

年初来

46.79%

1年

30.93%

5年間

-61.07%

10年間

5.68%

概要： Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.

従業員数： 2,556

情報技術ソフトウェア - アプリケーション

ニュース

ポジティブ

ニュートラル

ネガティブ

センチメント 3か月間

ポジティブ 42.9%

ニュートラル 57.1%

ネガティブ 0%

ニュートラル

Materialise NV to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the third quarter ended September 30, 2026 on Wednesday, October 28, 2026 at 2:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the third quarter 2026 financial results on Wednesday, October 28, 2026 at.

Materialise NV to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026

ポジティブ

Materialise: A High-Margin Medical Business Hiding In Plain Sight

Materialise's Medical continues to deliver double-digit growth and strong margins and is increasingly underpinning the company's value. The Manufacturing segment is recovering, with aerospace strength offsetting weak prototyping demand and creating significant potential for margin expansion. Software is now an uncertainty, as recurring revenue growth has stalled despite Materialise's transition toward subscriptions and the introduction of new CO-AM products.

Materialise: A High-Margin Medical Business Hiding In Plain Sight

ニュートラル

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

Materialise NV (MTLS) Q2 2026 Earnings Call Transcript

ポジティブ

Materialise Q2 Earnings Call Highlights

Materialise NASDAQ: MTLS reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue guidance, despite the anticipated revenue effect of divesting its RapidFit and Eyewear businesses.

Materialise Q2 Earnings Call Highlights

ニュートラル

Materialise Reports Second Quarter and Half-Year 2026 Results

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the second quarter and the six months ended June 30, 2026. Highlights – Second Quarter 2026 Total revenue increased by 8.1% to 70,073 kEUR for the second quarter of 2026 compared to 64,831 kEUR for the corresponding 2025 period. Adjusted EBITDA increased.

Materialise Reports Second Quarter and Half-Year 2026 Results

ニュートラル

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ: MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced that it will release financial results for the second quarter and the six months ended June 30, 2026 on Thursday, August 27, 2026 at 1:00 a.m. ET/7:00 a.m. CET. Senior management will hold a conference call to discuss the second quarter and the six months ended June 30, 2026 fina.

Materialise NV to Report Second Quarter and Half-Year 2026 Earnings on Thursday, August 27, 2026

ポジティブ

Materialise: Maturing Transition Should Lead To Stronger Performance Going Forward

While Materialise's Q1 results were soft, its Medical segment appears to be stabilizing and the software business model transition is nearing completion. Cost discipline and a return to growth should see margins start to consistently move higher, assuming that the macro environment remains stable. Despite the stock moving higher in recent months, a material improvement in performance still isn't priced into the stock.

Materialise: Maturing Transition Should Lead To Stronger Performance Going Forward

ニュートラル

Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions

LEUVEN, Belgium, July 01, 2026 (GLOBE NEWSWIRE) -- MATERIALISE NV Technologielaan 153001 LeuvenCompany number: 0441.131.254RPR Leuven

Annual General Meeting of Materialise NV held at the registered office of the Company on Tuesday 16 June 2026 at 10:00 (CET): Resolutions

ニュートラル

MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS' MEETING OF 16 JUNE 2026

LEUVEN, Belgium, June 17, 2026 (GLOBE NEWSWIRE) -- Regulated information [1]

MATERIALISE NV RESULTS OF ANNUAL GENERAL SHAREHOLDERS' MEETING OF 16 JUNE 2026

ポジティブ

Zacks Investment Research

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

Materialise (MTLS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

All You Need to Know About Materialise (MTLS) Rating Upgrade to Buy

ニュースランキングを見る

価格チャートは Lightweight Charts™ を使用して実装されています